Community
Iconic singer announces first show since brain surgery
By David Robinson
FDA says use of popular GLP-1 drugs may lead to a rare but very serious, side effect
David Robinson
David Robinson
Reporter · Lancaster, PA
David graduated from Franklin & Marshall College and has been a community journalist for over 8 years, previously working at the Lancaster Examiner. He focuses on the heart of Lancaster, covering local events, festivals, and community initiatives.
More from David →Reporter · Monday, November 9, 2026 at 10:39 PM · 1 min read
The Food and Drug Administration said the highly popular GLP-1 drugs will now carry a new warning on their labels after several reports of vision loss among users.
Up nextIconic singer announces first show since brain surgeryCommunity · 1 min read
